Miami GU Oncology Summit
Venue: Hyatt Regency Miami, 400 Southeast 2nd Street, Miami, FL, 33131, United States
Official conference page for Miami GU Oncology Summit. https://binaytara.org/projects/conferences/miami-gu-oncology-summit
About Miami GU Oncology Summit


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Agenda
Saturday, November 14th, 2026
All timings are in Eastern Time (EDT, GMT-04:00) time.
Session Chair: Rohan Garje, MD; Michael Carducci, MD
08:30 AM - 08:40 AM
Case Presentation: The case for upfront PSMA radioligand therapy: Should Pluvicto become the first-line standard for all PSMA-positive mAPMN/S prostate cancer?
08:40 AM - 08:50 AM
Case Presentation: The case for chemotherapy intensification: When is ADT + ARPI + docetaxel the preferred first-line triplet in mAPMN/S prostate cancer?
08:50 AM - 09:05 AM
Case-Based Panel Discussion
Moderators:
Rohan Garje, MD; Michael Carducci, MD
Panelists:
Vinay Minocha, MD
09:05 AM - 09:15 AM
Case Presentation: Upfront PARP inhibition in mAPMN/S prostate cancer: Is BRCA2 the defining biomarker, and who benefits beyond it?
09:15 AM - 09:25 AM
Case Presentation: Capivasertib + abiraterone + ADT in PTEN-deficient mAPMN/S prostate cancer: Defining the ideal candidate? – Jingsong Zhang, MD, PhD
09:25 AM - 09:45 AM
Case-Based Panel Discussion
Moderators:
Rohan Garje, MD; Michael Carducci, MD
Panelists:
Vinay Minocha, MD
Session Chair: Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD
09:45 AM - 09:55 AM
Case Presentation: The localized renal mass: Surgery, ablation, radiation, or surveillance?
09:55 AM - 10:05 AM
Case Presentation: Adjuvant therapy after nephrectomy: Who should we treat and with what?
10:05 AM - 10:20 AM
Case-Based Panel Discussion
Moderators:
Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD
Panelists:
Raju Vaddepally, MD
10:20 AM - 10:30 AM
Case Presentation: Metastatic disease: Choosing first-line therapy in clear-cell non–clear-cell
10:30 AM - 10:40 AM
Case Presentation: Non–clear-cell RCC: Histology, molecular drivers, and treatment selection
10:40 AM - 11:00 AM
Case-Based Panel Discussion
Moderators:
Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD
Panelists:
Raju Vaddepally, MD
Session Chair: Arnab Basu, MD; Manuel Ozambela, MD
11:15 AM - 11:25 AM
Case Presentation: Choosing among options in BCG-unresponsive NMIBC
11:25 AM - 11:35 AM
Case Presentation: Perioperative systemic therapy for MIBC — a moving target
11:35 AM - 11:50 AM
Case-Based Panel Discussion
Moderators:
Arnab Basu, MD; Manuel Ozambela, MD
Panelists:
Jan Krzysztof Rudzinski, MD
11:50 AM - 12:00 PM
Case Presentation: Bladder preservation options among patients with MIBC
12:00 PM - 12:10 PM
Case Presentation: Ideal systemic therapy for metastatic urothelial carcinoma
12:10 PM - 12:30 PM
Case-Based Panel Discussion
Moderators:
Arnab Basu, MD; Manuel Ozambela, MD
Panelists:
Jan Krzysztof Rudzinski, MD
01:30 PM - 01:40 PM
Case Presentation: Symptom management
01:40 PM - 01:50 PM
Case presentation: Drug interaction
01:50 PM - 02:05 PM
Case-Based Panel Discussion
02:05 PM - 02:15 PM
Case Presentation: Nurse navigator
02:15 PM - 02:25 PM
Case Presentation: Role of research coordinator in clinical trials
02:25 PM - 02:45 PM
Case-Based Panel Discussion
